UBS Maintains Neutral on McCormick & Co, Lowers Price Target to $48
UBS analyst Peter Grom maintains McCormick & Co (NYSE:MKC) with a Neutral and lowers the price target from $52 to $48.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
UBS analyst Peter Grom maintains McCormick & Co (NYSE:MKC) with a Neutral and lowers the price target from $52 to $48.
Lawrence Erik Kurzius, a Director at Cooper Companies, purchased 10,000 shares worth $549,300 at $54.93 per share on September 16, 2026, increasing his total holdings to 31,099 shares. The insider buy signals confidence in the company's recovery prospects following a 16% stock decline over the past year. The article notes that insider purchases typically predict higher share prices within 30 days and suggest management believes in the company's long-term growth, particularly after deciding to retain its surgical unit rather than divest it.
BNP Paribas analyst Max Gumport maintains McCormick & Co (NYSE:MKC) with a Outperform and lowers the price target from $75 to $65.
McCormick beats Q3 estimates with $2.02B sales and 86-cent EPS, reaffirms FY26 outlook; analysts cut price targets to $48.
The global nail care products market is projected to grow at a 7% CAGR from 2025 to 2033, driven by rising beauty awareness, at-home manicure solutions, e-commerce expansion, and social media trends. Clean beauty, vegan formulations, and sustainable packaging are gaining market share, while key challenges include chemical sensitivity concerns and counterfeit products. Asia Pacific is expected to post the fastest growth.
The global functional foods and beverages market is projected to grow from $365.1 billion in 2024 to $591.7 billion by 2030, with a CAGR of 8.6%. Growth is driven by consumer shift toward preventive health nutrition, premiumization, beverage innovation, and expansion in Asia-Pacific. North America leads with 34.3% market share, while emerging technologies like microbiome science and AI-driven personalization reshape competition.